Industry News
Abnormal blood clots in the brain offer drug target for Alzheimer's
Jul 01, 2014
Without a steady supply of blood, neurons can't work. That's why one of the culprits behind Alzheimer's disease is believed to be the persistent blood clots that often form in the brains of... Read More
In KRAS wild-type MCRC, equivalent survival offered by cetuximab or bevacizumab with combi chemo
Jul 01, 2014
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress... Read More
Back and abdomen pain an increased risk for colon cancer survivors
Jul 01, 2014
Researchers from the University of Granada discover that colon cancer patients experience abnormalities in processing chronic pain that increase their sensitization to pain of any kind in the... Read More
Predicting aggressiveness of oral cancer
Jul 01, 2014
Studying mouth cancer in mice, researchers have found a way to predict the aggressiveness of similar tumors in people, an early step toward a diagnostic test that could guide treatment, according to... Read More
Comprehensive review of treatments for depression in cancer patients
Jul 01, 2014
Depression is common in cancer, up to half of all patients facing the disease experience depressive symptoms, ranging from mild to severe. Read More
Potential new use for cancer drug in gene therapy for blood disorders
Jul 01, 2014
Scientists working to make gene therapy a reality have solved a major hurdle: how to bypass a blood stem cell's natural defenses and efficiently insert disease-fighting genes into the cell's genome. Read More
Family history is 'a bigger risk factor than lifestyle' for some cancers
Jun 30, 2014
Family history is a greater risk factor than lifestyle for developing some cancers, according to a Swedish study looking at 71,000 adopted people. Read More
Scientists map cell's DNA history to embryonic origin
Jun 30, 2014
By looking at mutations in a cell's DNA, scientists can work out how the cell has changed since its genetic origin in the fertilized egg. This could be useful for cancer research. Read More
Phase III trial shows improved survival with TAS-102 in metastatic colorectal cancer refractory to standard therapies
Jun 30, 2014
The new combination agent TAS-102 is able to improve overall survival compared to placebo in patients whose metastatic colorectal cancer is refractory to standard therapies, researchers said at the... Read More
Genetics dominant risk factor in common cancers
Jun 30, 2014
A study of individuals who have been adopted has identified genetics as the dominant risk factor in 'familial' breast, prostate and colorectal cancers. Read More
Previous Page Next Page